Real-world implementation, deployment and validation of early detection tools and lifestyle enhancement
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 27 projects and 1 programmes
Prediction of Alzheimer’s disease using an AI driven screening platform
Precision medicine platform in neurodegenerative disease
Synthetic data generation framework for integrated validation of use cases and AI healthcare applications
Alzheimer's disease apolipoprotein pathology for treatment elucidation and development
Amyloid imaging to prevent Alzheimer’s disease
Big Data for Better Outcomes
EBiSC2 – A sustainable European bank for induced pluripotent stem cells
European Platform for Neurodegenerative Diseases
European Quality In Preclinical Data
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
Inhibiting misfolded protein propagation in neurodegenerative diseases
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
Models of patient engagement for Alzheimer’s disease
Efficiently networking European neurodegeneration research
Parkinson disease with mild cognition impairment treated with nicotinic agonist drug
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Psychiatric ratings using intermediate stratified markers 2
Remote assessment of disease and relapse – Alzheimer’s disease
Real world outcomes across the AD spectrum for better care: multi-modal data access platform
Organising mechanistic knowledge about neurodegenerative diseases for the improvement of drug development and therapy
European Bank for induced pluripotent Stem Cells
European Medical Information Framework
European prevention of Alzheimer’s dementia consortium
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
